This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
BackgroundIndividuals diagnosed with type 2 diabetes mellitus (T2DM) commonly exhibit elevated lipid levels and an increased body mass index (BMI). The impact of BMI on the efficacy of statins in reducing lipid levels among diabetic patients remains uncertain.
In the US, over 45% of the population has either diabetes or pre-diabetes 1. The absolute majority of those with diabetes have type 2 diabetes, which is usually associated with excess visceral fat and poor cardiometabolic health. Because a diagnosis of diabetes is very likely to shorten your life. Pre-Diabetes.
Patients with low-to-normal body mass index (BMI; < 25.0 kg/m2) were underrepresented in major randomized controlled trials on sodium-glucose cotransporter 2 (SGLT2) inhibitors for type 2 diabetes. The present st.
BMI variability has been associated with increased cardiovascular disease risk in individuals with type 2 diabetes, however comparison between clinical studies and real-world observational evidence has been la.
In the study of 210 adults without diabetes, participants on tirzepatide. (MedPage Today) -- Tirzepatide (Zepbound) was effective at reducing body weight in Chinese adults with lower cutoffs for overweight or obesity, the SURMOUNT-CN trial reported.
Sensitivity analyses reconfirmed the robustness of the associations of CVD and hypertension with COPD severity among patients who excluded bronchiectasis, tuberculosis, lung cancer, pulmonary hypertension, pulmonary heart disease, and diabetes (P<0.05).ConclusionThe
Understanding the relationship between serum ferritin levels and cardiovascular outcomes in type 2 diabetes is crucial for improving risk stratification and guiding therapeutic interventions aimed at preventin.
(MedPage Today) -- Medical experts from around the globe proposed a more nuanced approach to diagnosing obesity that does not rely exclusively on body mass index (BMI) alone. Writing in The Lancet Diabetes & Endocrinology, the global commission.
No Diabetes or Pre-Diabetes. A study of almost 10,000 adults with obesity (BMI >30) who were evaluated for all LE8 factors and followed for over 7 years can give us some insight 1. Normal Blood Pressure. The answer is yes. The magnitude of that risk reduction will surprise you.
Excess weight, as measured by BMI, is typically considered a measure of excess body fat. Excess visceral fat results in a higher risk of insulin resistance, which is the precursor state to diabetes. When someone is classified as being of ‘normal’ weight, that typically means they have a BMI of less than 25.
Maternal height is linked to specific adverse pregnancy events in women with gestational diabetes mellitus, according to a new study. The investigators found shorter women had higher rates of low birth rate and primary c-sections, but taller women had higher rates of abnormal neonatal ponderal index, postpartum hemorrhage, and macrosomia.
Among patients without diabetes or cardiovascular disease and with a BMI 27 kg/m2, those with coronary artery calcium (CAC) scoring 300 derive the largest benefit from a weight-loss-dose of semaglutide for the prevention of major adverse cardiovascular events (MACE).
In this week's post, we take a deep dive into the latest study showing that red meat intake is associated with type 2 diabetes…one that caused quite a stir in the media. More meat, more diabetes? Model 3 is nearly identical to model 2, but omits the adjustment for BMI. This is where the authors make a very critical move.
What is the incremental benefit in patients with heart failure and preserved ejection fraction (HFpEF) of glucagon-like peptide-1 receptor agonists (GLP-1 RA) combined with sodium-glucose cotransporter 2 inhibitors (SGLT2i) in patients with type 2 diabetes mellitus (T2DM) and body mass index (BMI) ≥27?
Background:Poor self-care in patients with type 1 diabetes (T1DM) and type 2 diabetes (T2DM) leads to increased diabetes complications and health costs. 003), lower body mass index (BMI) (p =.040), 302), while lower BMI (p =.045) 003), lower body mass index (BMI) (p =.040), 302), while lower BMI (p =.045)
It all comes down to: What your priorities are What your objectives are Your risk tolerance Your ability to update that risk model Where you draw the line of ‘risk’ equating to ‘causation’ The same is true when it comes to the question of statins ‘causing’ diabetes. What to do? Let’s dive in.
BMI) to receive Roux-en-Y gastric bypass and medical therapy or only receive medical therapy, finding that after five years… Far more gastric bypass patients cut their BP medication use by at least 30% (80.7% The GATEWAY trial assigned 100 participants (76% women, 43.8 of them achieved BPs below 130/80 mm Hg (vs.
It increases the likelihood of developing chronic conditions such as heart disease, diabetes, and high blood pressure. Food and Drug Administration (FDA) in 2021 as a once-weekly injection for chronic weight management in adults with obesity and at least one weight-related condition such as type 2 diabetes or hypertension. at 36 weeks.
However, body mass index (BMI) was not associated with biological age acceleration. Finally, having dyslipidemia (abnormal levels of blood lipids) and diabetes were associated with a higher age acceleration. The early bird gets the worm. vitamin C , Beta-carotene ) — eat your fruits and veggies!
There are significant data that show that if you have obesity, you have a high risk of developing coronary heart disease, heart failure, type 2 diabetes (T2D) or risk factors such as hypertension and dyslipidemia. [1] These individuals tend to have a better prognosis when compared to both individuals with normal weight (BMI of 18.5
BMI, body mass index; eGFR, estimated glomerular filtration rate; NYHA, New York Heart Association. 1.29), diabetes mellitus (HR 1.15, 95% CI 1.04–1.27) Discontinuation and reinitiation of mineralocorticoid receptor antagonists (MRA) in patients with heart failure and reduced ejection fraction (HFrEF). 2.40), eGFR 30–60 ml/min/1.73 m
As I have written about before , the risk of all three conditions mentioned above, which are leading causes of death, are driven by poor metabolic health ranging from insulin resistance to the more extreme phenotype, type 2 diabetes. Thyroid disorders were about 53% less in the ideal group, but the real impact was on type 2 diabetes.
A 10 to 15kg weight loss in those who are overweight can reverse diabetes in 57% of patients with diabetes 1. Even in diabetics of normal weight (BMI<27), weight loss can reverse diabetes 2. 2 1184-P: Return to Normal Glucose Control by Weight Loss in Nonobese People with Type 2 Diabetes: The ReTUNE Study.
Body mass index (BMI) is a widely available marker of nutrition status, however studies on BMI and post-ICH outcomes are limited and have conflicting results. Patients were divided into underweight, normal weight, overweight, and obese according to World Health Organization BMI criteria. 7.34) and lobar (OR 3.15, 95% CI 1.67-5.94)
Growing Global Burden of Cardiometabolic Risks: The 2023 World Obesity Atlas projects a significant rise in global overweight and obesity levels by 2035, leading to a surge in diabetes cases.
In this study, we aim to analyze the MHO trends and outcomes with respect to Stroke.Methods:We queried the National Inpatient Sample (2016-2019) to identify Stroke hospitalizations in the elderly population (%E2%89%A565 years) with vs without MHO by using ICD-10 codes after excluding patients with Hypertension, analyze, and Diabetes Mellitus.
DM, diabetes mellitus; HTN, hypertension; LV, left ventricular; NP, natriuretic peptide; PCWP, pulmonary capillary wedge pressure; RV, right ventricular; SV, stroke volume. of patients had BMI ≥30 kg/m 2. Strain measurements in all four chambers were maintained as BMI increased. Overall, 60.9%
Background:GLP-1 receptor agonists (GLP1RA) agonists have been shown to reduce cardiovascular events in patients with type 2 diabetes (T2D) and atherosclerotic cardiovascular disease (ASCVD). Compared to the control group, the GLP1RA cohort had a higher baseline risk profile (BMI: 35.1 [SD Hispanic, 9.6% Asian, and 4.6% Hispanic, 9.6%
Conversely sleep apnea, elevated body mass index (BMI), diabetes mellitus, LA enlargement, antiarrhythmic drug use, and center's higher fluoroscopy use were related to reduced odds of FPI. Multivariate analysis showed that BMI > 30 (OR 0.78 [0.64–0.96]) 0.96]) and LA volume (OR per mL increase = 1.00 [0.99–1.00])
Reliability of self-reported risk factors was high in overweight (F1 0.81) and diabetes (F1 0.71), moderate in hearing impairment (F1 0.59) and hypertension (F1 0.56) and low in hypercholesterolemia (F1 0.49) and kidney disease (F1 0.25).
The mean BMI was 35.2 Pearson's correlations were used to test associations between xylitol, xylose, and 20 miRs associated with thrombosis and the clotting cascade, using the false discovery rate method to adjust for multiple comparisons.Results:Participants were 55 6 years (range 32-65) and 24% male. kg/m2, HbA1c was 5.9% 0.4,
BMI, body mass index; CV, cardiovascular; CVD, cardiovascular disease; HELLP, haemolysis, elevated liver enzymes, low platelet count. Shortly after delivery, women who experienced HDP express increased risk of classic CV risk factors such as hypertension, renal disease, abnormal lipid profile, and diabetes.
A, Normal axillary lymph nodes measuring milla1cf Fri, 05/10/2024 - 08:12 May 10, 2024 — According to the Summa Cum Laude Award-Winning Online Poster presented during the 124th ARRS Annual Meeting , fat-enlarged axillary nodes on screening mammograms can predict high cardiovascular disease (CVD) risk, Type 2 diabetes (T2DM), and hypertension (HTN).
17.4]) and was also more likely to have diabetes mellitus, hyperlipidemia, chronic lung disease, chronic kidney disease, chronic liver disease, BMI ≥ 25, anemia, metastatic cancer, and atrial fibrillation. The hemophilia cohort was slightly older (63.2[16.8]
were hypertensives, and 8 factors, including diabetes, age ≥65 years, higher waist circumference, (BMI) ≥30 kg/m2, lack of formal education, living in urban residence, family history of cardiovascular diseases, and dyslipidemia use were associated with hypertension.
Propensity score-matched analysis (PSM) (1:1) was performed on age, gender, BMI, hypertension, diabetes mellitus, chronic kidney disease, hemoglobin level, LDL level, left ventricular ejection fraction and various drugs including beta blockers, ACEi and ARBi. Both groups were followed for 12 months.
Outcomes were 1 year hospital readmission rates by all-cause and due to repeat stroke.Results:Patients in the intervention group and control group were similar in age, BMI, race, smoking status, as well as rates of hypertension, diabetes, hyperlipidemia, atrial fibrillation, and history of prior stroke, with the exception of discharge rate to skilled (..)
Participants with LVI were significantly older, male, Black, had higher BMI, and lower HDL. Participants with LVI were more likely to have diabetes, tobacco use, and atrial fibrillation (24% versus 14%, p<0.001). There were a total of 18 ischemic stroke events among those with LVI (6%) and 65 among those without LVI (3%).
The mean BMI was 27.9 One patient had diabetes, 8 had hyperlipidemia, and 9 had hypertension. Of these, 9 (64%) were female with a mean age of 59.6, and 5 (36%) were male with a mean age of 55.4. kg/m2, with 4 classified as obese. All patients were nonsmokers; 2 had a family history of stroke.
Propensity score-matched analysis (PSM) (1:1) was performed with matching for age, gender, race, BMI, hypertension, diabetes mellitus, chronic kidney disease, hemoglobin level, low-density lipid (LDL) level, left ventricular ejection fraction, and various drugs including ACEi, ARBi, ARNI, beta-blockers, and diuretics.
Falling into the class of obesity with a BMI of greater than 30 makes this more likely, but so also does having excess visceral fat deposition with significant metabolic consequences at a BMI less than 30. The distinction here is the metabolic consequences of excess fat causing a health risk rather than focusing on the BMI cutoff.
Calculate your body mass index (BMI) to determine whether you are within a healthy weight range for your height. Keep track of your blood pressure, cholesterol levels, and blood sugar levels if you have diabetes. Maintain a Healthy Weight Excess weight can strain your heart and increase your risk of heart disease.
A healthy lifestyle, in this instance, is defined by a combination of: BMI Nutrition Smoking Status Activity Levels Blood Pressure Diabetes Status Cholesterol Levels All of which are highly modifiable.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content